In addition, upregulation of the SPP1 signaling pathway was also observed in mM2-like TAMs (Supplementary Figure S2B), with the poor prognosis-associated characteristics of SPP1 in most cancers including PAAD, as previously reported (Liu et al., 2022c). This evidence concerns the gene SPP1 and pancreatic adenocarcinoma.